Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1222
Embargo will expire:
10-Dec-2018 11:00 AM EST
Released to reporters:
9-Dec-2018 11:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 705116

Opioid Prescriptions Can Be Drastically Reduced After Surgery with No Increase in Pain, Study Shows Striking

Roswell Park Comprehensive Cancer Center

Pain after surgery can be effectively managed with minimal or no opioids, according to research conducted at Roswell Park Comprehensive Cancer Center and published today in JAMA Network Open. A two-year study by a multidisciplinary team of surgeons and other cancer specialists shows that the amount of opioid medications prescribed after surgery can be drastically reduced without negatively affecting pain scores, postoperative complications or patient requests for additional

Released:
7-Dec-2018 11:05 AM EST
Embargo will expire:
10-Dec-2018 11:00 AM EST
Released to reporters:
6-Dec-2018 3:00 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 704857

Moffitt Researchers Identify Novel Mechanism to Thwart KRas-driven Tumor Growth

Moffitt Cancer Center

Researchers at Moffitt Cancer Center are trying to devise alternative mechanisms to block KRas. Their recent study demonstrates that the protein GSK3 is an important mediator of KRas-dependent tumor viability. Their research was published today in Nature Communications.

Released:
4-Dec-2018 11:05 AM EST
  • Embargo expired:
    3-Dec-2018 7:00 PM EST

Article ID: 704740

Dana-Farber Scientists to Present Research on Myeloma Progression From Precursor Conditions and Novel Approaches to Treatment

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the ASH Annual Meeting.

Released:
3-Dec-2018 10:30 AM EST
  • Embargo expired:
    3-Dec-2018 6:30 PM EST

Article ID: 704709

Dana-Farber Scientists to Present New Research on Improving Outcomes in Stem Cell Transplantation for Myeloid Cancers

Dana-Farber Cancer Institute

Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation is a focus of several studies to be presented by Dana-Farber Cancer Institute scientists at the ASH Annual Meeting.

Released:
3-Dec-2018 6:30 PM EST

Article ID: 704762

New Study Reveals Gut Microbes May Help Protect People Having a Bone Marrow Transplant

Memorial Sloan Kettering Cancer Center

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.

Released:
3-Dec-2018 10:05 AM EST

Showing results

110 of 1222

Chat now!